ET1402L1-ARTEMIS™ T cells -IV
XJTU1AF2017LSL-C002
Phase 1 mab completed
Quick answer
ET1402L1-ARTEMIS™ T cells -IV for Hepatocellular Carcinoma is a Phase 1 program (mab) at AEON Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AEON Biopharma
- Indication
- Hepatocellular Carcinoma
- Phase
- Phase 1
- Modality
- mab
- Status
- completed